NCT00675350 2014-05-12Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsTeva Branded Pharmaceutical Products R&D, Inc.Phase 1 Completed12 enrolled